HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment.
about
The Community Liaison Program: a health education pilot program to increase minority awareness of HIV and acceptance of HIV vaccine trialsCombination HIV prevention interventions: the potential of integrated behavioral and biomedical approachesA systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific IslandersTaking culture seriously in biomedical HIV prevention trials: a meta-synthesis of qualitative studies.Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical preventionCandidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunitiesHIV vaccine trial preparedness among Spanish-speaking Latinos in the US.In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine StudyPromoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?How acceptable is it for HIV positive African, Caribbean and Black women to provide breast milk/fluid samples for research purposes?Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?Endorsement of compulsory HIV vaccination policy among populations at high risk of HIV exposure (LA VOICES).Willingness to participate in HIV vaccine trials: the impact of trial attributes.HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approachDevelopment and psychometric assessment of a multidimensional measure of internalized HIV stigma in a sample of HIV-positive adults.An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, TanzaniaFuture HIV vaccine acceptability among young adults in South Africa.Decisions to participate in research: views of underserved minority drug users with or at risk for HIVLong-chain peer referral to recruit black MSM and black transgender women for an HIV vaccine efficacy trial.Theoretical model of critical issues in informed consent in HIV vaccine trialsDevelopment of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICESBarriers to adolescents' participation in HIV biomedical prevention researchTime will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuationWillingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach.Project VOGUE: A partnership for increasing HIV knowledge and HIV vaccine trial awareness among House Ball leaders in Western New York.Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups.Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.Socioecological influences on community involvement in HIV vaccine research"Once Bitten, Twice Shy": participant perspectives in the aftermath of an early HIV vaccine trial termination.Conceptual framework for behavioral and social science in HIV vaccine clinical research.Evaluation of a social marketing campaign to increase awareness of immunizations for urban low-income childrenEngaging members of African American and Latino communities in preventive HIV vaccine trials.Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in UgandaMotivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, TanzaniaRetention of clinical trial participants in a study of nongonococcal urethritis (NGU), a sexually transmitted infection in men.Factors influencing willingness to participate in new drug trial studies: a study among parents whose children were recruited into these trials in northern Ghana.Knowledge and Perceptions about Clinical Trials and the Use of Biomedical Samples: Findings from a Qualitative Study in Rural Northern GhanaCognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users
P2860
Q24597056-4DA922A9-763F-44BB-8FC8-E06FAAE6E6DCQ27005602-C8C0AD7C-51B6-411E-A37D-CA981DAD7E0AQ27012187-EBB18943-27B3-4119-93D8-4099C3B34454Q30202107-429B77BA-3582-471B-8513-3E9F5BE830A0Q30206105-9A994989-6484-4360-A8B0-473AE3C6E3D6Q30226978-2AFDB340-E722-4677-8987-4315017385B0Q30230248-8FD5563C-F53E-41BC-8E40-A8D6D41607FFQ30378981-ADBEFC89-9CA5-49C6-81F8-2D980BA6E86CQ30392323-F4972DA1-D649-418D-B115-9556A18D5703Q30834066-6EA1E099-825D-4106-9C98-0AC44FD3FE1AQ30983687-83CC8517-38F1-4284-A84A-38F1DCBAAEE6Q33586189-168B5F4E-1C69-49E8-83C3-32C8F9316060Q33638974-F8A46BF9-BCE6-4A83-8754-14A3352F97B1Q33643631-99693D6F-0117-42F0-AF07-36A9DC0C95EFQ33689222-6716DDB0-5EC4-4D61-8340-97F375520854Q33805453-04018092-149E-4165-9A54-77026B9B87B8Q33807022-A07CBD70-AB61-4093-A565-526BE4BDC4D3Q33831829-3D033121-6A0C-4E4F-850F-F459480239F2Q33835788-0A26E1FE-DBE3-4910-A7CE-C31B578A86FAQ33865695-DAF9C0B1-7A8E-4ADE-8CEF-9543F7F26D62Q33987449-E4102E0F-EC16-4AA4-8B58-D22860B9DA62Q34005683-EFE487EE-C0C1-4B90-86D3-3868132450D5Q34063486-BC796556-C54B-4D5A-876C-05061DF54EA5Q34078448-85FB7F33-5A3F-41D9-B762-F0C4656D5268Q34376994-E208B94E-ECCC-4D41-B3A1-EB78AABFB507Q34506717-DD1E3898-DA9B-4609-8F3F-62D778BD3FA3Q35019252-23BAD88D-3B2E-4A90-A2C0-E5729852D7C6Q35131721-AFF5AEC7-859B-4298-84C8-3C765D276EAFQ35187935-30EF2AAC-50A1-46C3-B867-49EF81C61E4EQ35207849-C92EA69A-C9F8-4A17-A8D4-EA8106C13869Q35219438-96AEA0D3-8B36-478B-B596-BB16AE744D9EQ35301155-1896ADDE-7ADD-451A-8BE3-A6648C7DE988Q35335726-C9013F5A-C7AE-49E4-A572-5990A9541B9CQ35736408-75263719-E6A5-4E34-9361-42AA52DACE76Q35863340-40D71B97-1FA3-4835-9727-3D2E9FEA3B90Q35934431-397E6811-3DA5-4A71-86A5-619161EE2524Q35942053-A8CC036B-AB1B-4ABA-A990-5F3E8A8DDE57Q35943681-C7D68CAD-F3DB-4EA9-9F41-5FECDBAAE6E6Q35976778-BAF9367B-F405-4BE8-A975-ABE661875D27Q36283432-72FEFC5D-00F6-4319-B9BB-B1350BC0A69A
P2860
HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
HIV vaccine trial participatio ...... implications for recruitment.
@en
HIV vaccine trial participatio ...... implications for recruitment.
@nl
type
label
HIV vaccine trial participatio ...... implications for recruitment.
@en
HIV vaccine trial participatio ...... implications for recruitment.
@nl
prefLabel
HIV vaccine trial participatio ...... implications for recruitment.
@en
HIV vaccine trial participatio ...... implications for recruitment.
@nl
P2093
P1476
HIV vaccine trial participatio ...... implications for recruitment.
@en
P2093
Danielle Seiden
Ellen T Rudy
Kathleen J Roberts
Naihua Duan
Svetlana Popova
P304
P356
10.1097/01.QAI.0000179454.93443.60
P407
P577
2006-02-01T00:00:00Z